Predictive Oncology (POAI) Price & Analysis

Compare

530 Followers

POAI Stock Chart & Stats

$5.95

-$0.38(-22.49%)

At close: Jan 08 4:00 PM EST

$5.95

-$0.38(-22.49%)

Day’s Range― - ―

52-Week Range$3.88 - $45.90

Previous CloseN/A

Volume663.11K

Average Volume (3M)173.82K

Market Cap

$14.46M

Enterprise Value$9.17M

Total Cash (Recent Filing)$181.67K

Total Debt (Recent Filing)$1.70M

Price to Earnings (P/E)―

Beta0.92

Next Earnings

Apr 08, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-107.25

Shares Outstanding3,393,516

10 Day Avg. Volume72,596

30 Day Avg. Volume173,821

Financial Highlights & Ratios

PEG Ratio0.15

Price to Book (P/B)-331.08

Price to Sales (P/S)41.31

P/FCF Ratio-6.11

Enterprise Value/Market Cap0.63

Enterprise Value/Revenue12.59

Enterprise Value/Gross Profit25.05

Enterprise Value/Ebitda-0.11

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.

Bears Say

Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.

Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.

Predictive Oncology News

Predictive Oncology announces name change to Axe Compute

Axe Compute (AGPU) has changed its name to Axe Compute Inc., with its common stock to begin trading...

12d ago

POAI

Predictive Oncology regains compliance with Nasdaq minimum stockholder equity

Predictive Oncology (POAI) announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying...

22d ago

POAI

Predictive Oncology Rebrands to Axe Compute Inc. on Nasdaq

An announcement from Predictive Oncology ( ($POAI) ) is now available. On December 10, 2025, Axe Compute Inc....

11d ago

POAI

Predictive Oncology Rebrands to Axe Compute Inc.

Predictive Oncology ( ($POAI) ) has provided an update. Predictive Oncology Inc., a company involved in the field...

13d ago

POAI

Predictive Oncology Regains Nasdaq Compliance

Predictive Oncology ( ($POAI) ) has provided an update. On December 1, 2025, Predictive Oncology Inc. announced that...

21d ago

POAI

Predictive Oncology Stockholders Approve Key Proposals

Predictive Oncology ( ($POAI) ) has shared an announcement. At the Annual Meeting, Predictive Oncology‘s stockholders voted on...

28d ago

POAI

Predictive Oncology Regains Nasdaq Compliance with Investments

Predictive Oncology ( ($POAI) ) just unveiled an update. Predictive Oncology Inc. has announced that it has regained...

1M ago

POAI

Predictive Oncology Expands into Digital Asset Management

Predictive Oncology Inc ( ($POAI) ) has released its Q3 earnings. Here is a breakdown of the information...

1M ago

POAI

Predictive Oncology Unveils New Digital Asset Strategy

An update from Predictive Oncology ( ($POAI) ) is now available. On November 17, 2025, Predictive Oncology Inc....

1M ago

POAI

Predictive Oncology Inc trading resumes

09:41 EST Predictive Oncology (POAI) Inc trading resumes Published first on TheFly – the ultimate source for real-time,...

1M ago

POAI

Predictive Oncology Inc trading halted, volatility trading pause

09:31 EST Predictive Oncology (POAI) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate...

1M ago

POAI

Predictive Oncology Updates ATM Offering Program

The latest announcement is out from Predictive Oncology ( ($POAI) ). On October 29, 2025, Predictive Oncology Inc....

2M ago

POAI

Predictive Oncology files to sell 14.9M shares of common stock for holders

17:29 EDT Predictive Oncology (POAI) files to sell 14.9M shares of common stock for holders Published first on...

2M ago

POAI

Predictive Oncology files to sell 5.97M shares of common stock for holders

17:29 EDT Predictive Oncology (POAI) files to sell 5.97M shares of common stock for holders Published first on...

2M ago

POAI

POAI FAQ

What was Predictive Oncology Inc’s price range in the past 12 months?

Predictive Oncology Inc lowest stock price was $3.88 and its highest was $45.90 in the past 12 months.

What is Predictive Oncology Inc’s market cap?

Predictive Oncology Inc’s market cap is $14.46M.

When is Predictive Oncology Inc’s upcoming earnings report date?

Predictive Oncology Inc’s upcoming earnings report date is Apr 08, 2026 which is in 105 days.

How were Predictive Oncology Inc’s earnings last quarter?

Predictive Oncology Inc released its earnings results on Nov 14, 2025. The company reported -$107.25 earnings per share for the quarter, missing the consensus estimate of N/A by -$107.25.

Is Predictive Oncology Inc overvalued?

According to Wall Street analysts Predictive Oncology Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Predictive Oncology Inc pay dividends?

Predictive Oncology Inc does not currently pay dividends.

What is Predictive Oncology Inc’s EPS estimate?

Predictive Oncology Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Predictive Oncology Inc have?

Predictive Oncology Inc has 3,393,516 shares outstanding.

What happened to Predictive Oncology Inc’s price movement after its last earnings report?

Predictive Oncology Inc reported an EPS of -$107.25 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.173%.

Which hedge fund is a major shareholder of Predictive Oncology Inc?

Currently, no hedge funds are holding shares in POAI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Predictive Oncology Inc

Predictive Oncology (POAI) is a biotechnology company focused on advancing personalized medicine through the use of artificial intelligence and data analytics. The company operates primarily in the healthcare sector, specializing in the development of predictive models that help predict patient responses to cancer treatments. Their core products include a proprietary platform that analyzes tumor samples and treatment data to optimize therapeutic strategies tailored to individual patients.

Predictive Oncology (POAI) Earnings & Revenues

Historic Earnings Reports

POAI Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted significant advancements in AI-driven biomarker discovery, strategic partnerships, and cost reduction initiatives, despite a decline in quarterly revenue and consolidation of non-profitable operations.View all POAI earnings summaries